| In-vitro blood-brain barrier models for drug screening and permeation studies: an overview S Bagchi, T Chhibber, B Lahooti, A Verma, V Borse, RD Jayant Drug design, development and therapy, 3591-3605, 2019 | 213 | 2019 |
| Nanomedicine for the SARS-CoV-2: state-of-the-art and future prospects SP Varahachalam, B Lahooti, M Chamaneh, S Bagchi, T Chhibber, ... International journal of nanomedicine, 539-560, 2021 | 80 | 2021 |
| CNS organoids: an innovative tool for neurological disease modeling and drug neurotoxicity screening T Chhibber, S Bagchi, B Lahooti, A Verma, A Al-Ahmad, MK Paul, ... Drug discovery today 25 (2), 456-465, 2020 | 55 | 2020 |
| Therapeutic role of inflammasome inhibitors in neurodegenerative disorders B Lahooti, T Chhibber, S Bagchi, SP Varahachalam, RD Jayant Brain, Behavior, and Immunity 91, 771-783, 2021 | 33 | 2021 |
| Farnesyl Transferase Inhibitors as Potential Anticancer Agents S Bagchi, P Rathee, V Jayaprakash, S Banerjee Mini Reviews in Medicinal Chemistry 18 (19), 1611-1623, 2018 | 30 | 2018 |
| Hydrogels in tissue engineering T Chhibber, R Shinde, B Lahooti, S Bagchi, SP Varahachalam, A Gaddam, ... Intelligent Hydrogels in Diagnostics and Therapeutics, 105-122, 2020 | 27* | 2020 |
| The finer aspects of grid-walking and cylinder tests for experimental stroke recovery studies in mice N Syeara, S Bagchi, A Al Shoyaib, ST Karamyan, FF Alamri, VT Karamyan Neural Repair: Methods and Protocols, 345-353, 2023 | 4 | 2023 |
| In vitro models of central nervous system barriers for blood-brain barrier permeation studies S Bagchi, B Lahooti, T Chhibber, S Varahachalam, R Mittal, A Joshi, ... Nanomedicines for Brain Drug Delivery, 235-253, 2021 | 4 | 2021 |
| Evaluation of Systemic and Brain Pharmacokinetic Parameters for Repurposing Metformin Using Intravenous Bolus Administration S Sharma, Y Zhang, D Patel, KA Akter, S Bagchi, AE Sifat, E Nozohouri, ... Journal of Pharmacology and Experimental Therapeutics, 2024 | 1 | 2024 |
| High throughput virtual screening based discovery of dengue protease inhibitor S Bagchi, U Alia, F Mohammad, MUM Siddique Journal of Pharmaceutical Chemistry 4 (3), 35-40, 2017 | 1 | 2017 |
| Structural basis of divergent substrate recognition and inhibition of human neurolysin K Shi, S Bagchi, J Bickel, SH Esfahani, L Yin, T Cheng, VT Karamyan, ... Scientific Reports 14 (1), 18420, 2024 | | 2024 |
| Systemic and Brain Pharmacokinetics of Milnacipran in Mice: Comparison of Intraperitoneal and Intravenous Administration S Bagchi, E Nozohouri, Y Ahn, D Patel, U Bickel, VT Karamyan Pharmaceutics 16 (1), 53, 2023 | | 2023 |
| Role of Gut–Brain Axis in HIV-1 Infection T Chhibber, B Lahooti, SP Varahachalam, S Bagchi, A Joshi, RD Jayant Gut–Brain Connection, Myth or Reality? Role of The Microbiome in Health and …, 2022 | | 2022 |
| Multifunctional Nanotherapeutics for the Treatment of NeuroHIV RDJ Sounak Bagchi FASEB 34 (S1), 1-1, 2020 | | 2020 |
Behnaz LahootiNon-viral gene delivery postdoc fellow @ Sanofi在 ttuhsc.edu 的电子邮件经过验证
Behnaz LahootiNon-viral gene delivery postdoc fellow @ Sanofi在 ttuhsc.edu 的电子邮件经过验证
Sugato BanerjeeAssociate Professor NIPER Kolkata在 niperkolkata.ac.in 的电子邮件经过验证